Influenza Vaccination Effective Against Coronary Artery Disease and Acute Coronary Syndrome - medtigo



Influenza Vaccination Effective Against Coronary Artery Disease and Acute Coronary Syndrome

Share on facebook
Share on twitter
Share on linkedin
Share on whatsapp

Coronary artery disease (CAD) is a common medical condition affecting millions worldwide. It results from atherosclerosis, a process in which fatty deposits, or plaque, build up in the walls of arteries, reducing blood flow to the heart. Patients with CAD are at a higher risk of developing complications, such as heart attacks and strokes.  

Influenza is a respiratory illness caused by influenza viruses that can cause significant morbidity and mortality, particularly in vulnerable populations. Patients with CAD are at a higher risk of severe influenza-related complications due to their compromised cardiovascular system. Influenza infection can cause an acute exacerbation of CAD, leading to acute coronary syndrome (ACS), a medical emergency that requires immediate treatment.  

According to The American Journal of Medicine, influenza vaccination is a proven intervention to reduce the risk of influenza infection and its associated complications. It is recommended by the Centers for Disease Control and Prevention (CDC) for all individuals aged six months and older, particularly those at higher risk of influenza-related complications, such as patients with CAD. 

The meta-analysis, which assessed the effectiveness of influenza vaccination in patients with ACS and stable CAD, found that the influenza vaccine significantly reduced the risk of all-cause mortality, cardiovascular mortality, major acute cardiovascular events, and ACS. These findings are consistent with previous studies that have demonstrated the benefits of influenza vaccination in reducing cardiovascular events and mortality in patients with CAD.  

The researchers also found that influenza vaccination did not reduce the risk of revascularization, stroke or transient ischemic attack, or heart failure hospitalization. These results suggest that while influenza vaccination can reduce the risk of cardiovascular events and mortality in patients with CAD, it may not significantly impact other outcomes.  

Despite the proven benefits of influenza vaccination, vaccination rates among patients with CAD remain low. A study conducted in the United States found that only 55% of patients with CAD received influenza vaccination during the 2019-2020 season. This underscores the need for healthcare providers to prioritize influenza vaccination in this vulnerable population and educate patients on the importance of vaccination in reducing influenza-related complications.

One of the most significant advantages of the influenza vaccine is its relatively cheap and effective intervention. Patients with coronary artery disease who receive the vaccine are less likely to develop severe flu symptoms that could weaken their heart muscles and lead to cardiovascular complications. Moreover, the vaccine can boost the immune system and improve overall health, reducing the risk of developing long-term health issues.  

In conclusion, the meta-analysis provides strong evidence for the benefits of influenza vaccination in reducing the risk of mortality and major cardiovascular events in patients with CAD, particularly those with ACS. Therefore, healthcare providers should encourage patients with coronary artery disease to receive the influenza vaccine, particularly those with the acute coronary syndrome. 


Free CME credits

Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.

Digital Certificate PDF

On course completion, you will receive a full-sized presentation quality digital certificate.

medtigo Simulation

A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.

medtigo Points

medtigo points is our unique point redemption system created to award users for interacting on our site. These points can be redeemed for special discounts on the medtigo marketplace as well as towards the membership cost itself.
  • Registration with medtigo = 10 points
  • 1 visit to medtigo’s website = 1 point
  • Interacting with medtigo posts (through comments/clinical cases etc.) = 5 points
  • Attempting a game = 1 point
  • Community Forum post/reply = 5 points

    *Redemption of points can occur only through the medtigo marketplace, courses, or simulation system. Money will not be credited to your bank account. 10 points = $1.

All Your Certificates in One Place

When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.

Our Certificate Courses